Depon Maximum 1000mg Paracetamol

Depon is a long-standing and highly recognizable analgesic brand in Greece, primarily known for its paracetamol-based formulations used to alleviate pain and reduce fever. Originally launched and developed by the French pharmaceutical company UPSA (Union de Pharmacie Salicylique Appliquée), the brand has become a household name in the Greek market through decades of availability.

The manufacturing of Depon Maximum typically occurs at UPSA's primary industrial facilities in Agen, France, which serve as the global hub for the brand's production. Throughout its history, the ownership of the brand has transitioned through several major pharmaceutical entities. It was previously part of Bristol-Myers Squibb's portfolio for many years before being acquired by Taisho Pharmaceutical. This ownership structure ensures that the brand benefits from Japanese pharmaceutical expertise while maintaining its historic European manufacturing roots.

The packaging displayed features Greek text and Braille, indicating it is specifically localized for the Hellenic market. The brand continues to be a market leader in the region, distributed through local pharmacies as an over-the-counter solution for symptomatic relief.